Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
December 1, 2022 11:28 amMelendez, A. V., R. M. Velasco Cardenas, S. Lagies, J. Strietz, L. Siukstaite, O. S. Thomas, J. Tomisch, W. Weber, B. Kammerer, W. Romer, and S. Minguet. 2022. Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells. Cell Mol Life Sci 79: 513. doi: 10.1007/s00018-022-04524-7.
Categorised in:
This post was written by Heike Ufheil
